A recent study demonstrated that the combined therapy of radiation (RT) and metformin suppresses the progression of prostate cancer (PCa) by modulating the QKI/circZEB1/miR-141-3p/ZEB1 signaling pathway, enhancing radiation sensitivity. Here, QKI is linked to prostate cancer.